Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 144,400 | 657,000 | 252,895 | 254,822 | 175,315 |
| Depreciation Amortization | 166,600 | 59,000 | 65,449 | 50,187 | 17,592 |
| Income taxes - deferred | 395,500 | -154,000 | 92,831 | 71,155 | 42,066 |
| Accounts receivable | -115,800 | -28,000 | -116,439 | -72,870 | -78,778 |
| Other Working Capital | -415,200 | 158,000 | 109,639 | -14,053 | -17,183 |
| Other Operating Activity | 499,700 | -52,000 | 92,974 | 121,372 | 131,072 |
| Operating Cash Flow | $675,200 | $640,000 | $497,349 | $410,613 | $270,084 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 635,000 | -85,000 | -988,497 | N/A | 94,458 |
| PPE Investments | -286,300 | -137,000 | -29,329 | -21,846 | -21,982 |
| Net Acquisitions | -3,939,300 | N/A | N/A | -605,735 | -105,886 |
| Other Investing Activity | 5,400 | -1,000 | -9,315 | -4 | -307 |
| Investing Cash Flow | $-3,585,200 | $-223,000 | $-1,027,141 | $-627,585 | $-33,717 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 200,000 | N/A | N/A | 115,000 | 60,000 |
| Debt Issued | 3,500,000 | N/A | N/A | 240,000 | N/A |
| Debt Repayment | -101,200 | -55,000 | -36,000 | -91,000 | N/A |
| Common Stock Issued | 82,000 | 114,000 | 71,281 | 528,650 | 35,765 |
| Common Stock Repurchased | -327,700 | -303,000 | -66,136 | -11,553 | N/A |
| Other Financing Activity | -368,000 | 251,000 | 102,494 | -114,721 | -56,715 |
| Financing Cash Flow | $2,985,100 | $7,000 | $71,639 | $666,376 | $39,050 |
| Exchange Rate Effect | -9,000 | -10,000 | -1,491 | -768 | -1,697 |
| Beginning Cash Position | 944,000 | 530,000 | 989,501 | 540,865 | 267,145 |
| End Cash Position | 1,010,100 | 944,000 | 529,857 | 989,501 | 540,865 |
| Net Cash Flow | $66,100 | $414,000 | $-459,644 | $448,636 | $273,720 |
| Free Cash Flow | |||||
| Operating Cash Flow | 675,200 | 640,000 | 497,349 | 410,613 | 270,084 |
| Capital Expenditure | -286,300 | -137,000 | -29,329 | -21,846 | -21,982 |
| Free Cash Flow | 388,900 | 503,000 | 468,020 | 388,767 | 248,102 |